Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03212144 · ClinicalTrials.gov registry record · NA
The Anti-Inflammatory Effects of Exercise and Peanut Consumption
A NA study, sponsored by New York State Psychiatric Institute.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT03212144 is a NA study that was terminated before completion, run by New York State Psychiatric Institute. The registered enrollment target is 3 participants.
The verdict
NCT03212144, a NA study, was terminated before completion, sponsored by New York State Psychiatric Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study will enroll and randomly assign 30 sedentary, healthy overweight men and women to two groups. Participants will either start by consuming peanuts for 4 weeks, and then go on to exercise at high intensity intervals (HIIT) for 4 weeks, or the reverse order. The study will test and compare the effect of peanuts and exercise on inflammation and heart rate variability as indicators of heart health. Specifically, the study will measure inflammation in the blood because there is evidence that higher inflammation is found in heart disease patients. There is also evidence that inflammation is related to death as a result of heart disease in healthy individuals. Finally, there are ongoing trials targeting these markers to improve heart health. The study hypothesizes that peanuts and exercise will reduce inflammation. It is also expected to find less inflammation because exercise and peanut consumption activate a part of the nervous system that has been shown to cause a similar effect. Additionally, previous studies show that inflammation involves the mitochondria in the cell, the part of the cell that produces energy. For this reason, it is expected that exercise and peanuts will cause changes in the mitochondria. The study will test and compare mitochondrial activity in response to peanut consumption and exercise.
Interventions
- OTHER High Intensity Interval Training
- OTHER Peanut Consumption
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2017-08-20 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03212144
The ClinicalTrials.gov registry entry for NCT03212144 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which High Intensity Interval Training is the first listed.
NCT03212144 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03212144 about?
NCT03212144 is a clinical study titled "The Anti-Inflammatory Effects of Exercise and Peanut Consumption". This study will enroll and randomly assign 30 sedentary, healthy overweight men and women to two groups. Participants will either start by consuming peanuts for 4 weeks, and then go on to exercise at high intensity intervals (HIIT) for 4 weeks, or the reverse order. The study will test and compare t...
What is the current status of trial NCT03212144?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2017-08-20. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03212144?
The interventions under investigation include: High Intensity Interval Training (OTHER), Peanut Consumption (OTHER).
Who is sponsoring clinical trial NCT03212144?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.